Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel heterocyclic thyromimetics.

Helmut Haning1, Michael Woltering, Ulrich Mueller

  • 1BAYER HealthCare AG, Business Group Pharma, D-42096 Wuppertal, Germany. helmut.haning@bayerhealthcare.com

Bioorganic & Medicinal Chemistry Letters
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National Cohort.

NPJ Parkinson's disease·2026
Same author

Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results.

Deutsches Arzteblatt international·2026
Same author

Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer.

JCO precision oncology·2026
Same author

Individual and combined associations of physical activity and cognitive function with all-cause mortality in older men and women: a prospective analysis of the German National Cohort (NAKO).

BMC geriatrics·2026
Same author

Exome sequencing identifies known and candidate genes in hearing impairment in Cameroon.

Communications medicine·2026
Same author

Transportation noise and self-rated health: Evidence from the German national cohort (NAKO).

Environmental research·2026
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
Same journal

Novel 1H-pyrrole-2,5-dione derivatives as potential anti-diabetic agents: design, synthesis, in vitro, in ovo, and molecular docking studies.

Bioorganic & medicinal chemistry letters·2026
See all related articles

Novel thyromimetics with indole or indazole structures show potent activity. These compounds, designed to mimic thyroid hormone, exhibit moderate selectivity for the thyroid hormone beta receptor (THRbeta).

Area of Science:

  • Medicinal Chemistry
  • Endocrinology
  • Drug Discovery

Background:

  • Thyroid hormone receptors (THR) are critical regulators of metabolism.
  • Existing thyromimetics often target THRalpha or THRbeta isoforms.
  • Development of selective THRbeta agonists is of therapeutic interest.

Purpose of the Study:

  • To synthesize and characterize novel heterocycle-fused thyromimetics.
  • To evaluate the agonist activity and isoform selectivity of these new compounds.
  • To explore structure-activity relationships (SAR) for these novel thyromimetics.

Main Methods:

  • Synthesis of indole- and indazole-fused thyromimetic compounds.
  • In vitro evaluation of thyroid hormone receptor (THR) agonist activity.

Related Experiment Videos

  • Isoform-selective transient transfection assays to determine THRbeta selectivity.

    • Main Results:

    • Novel thyromimetics incorporating indoles or indazoles were successfully synthesized.
    • Potent agonist activity was identified in both indole and indazole series.
    • Moderate THRbeta selectivity (approximately 10-fold) was observed in the indole series.

    Conclusions:

    • Heterocycle-fused thyromimetics represent a promising new class of THR agonists.
    • SAR trends are consistent with known thyromimetics, validating the design approach.
    • The indole series demonstrates potential for developing selective THRbeta modulators.